Agendia has named Peter Wulff as vice president of finance and chief financial officer.
Wulff has more than 25 years of experience with financial management and corporate governance in the life sciences industry, the Dutch molecular diagnostics firm said. He is also a certified management accountant.
Wulff, who is originally from The Netherlands, will split his time between Agendia's locations in Amsterdam and Irvine, Calif., the firm said.
Illumina has appointed Marc Stapley as senior vice president and chief financial officer. Christian Henry, who had been serving as both chief financial officer and general manager of Illumina's genetic analysis business, will continue to head the genetic analysis business. The change will go into effect on Jan. 20.
Stapley joins Illumina from Pfizer, where he served as senior vice president responsible for global financial processes and systems. Previously, he held various senior finance roles at Alcatel-Lucent. He also worked as finance director and controller for several groups at Cadence Design Systems.
Stan Rose has been named chief commercial officer at Nabsys, a DNA sequencing technology company.
Rose formerly was CEO of NimbleGen Systems prior to its acquisition by Roche in 2007. He also co-founded Genetic MicroSystems, and he directed PerkinElmer's and Applied Biosystems' PCR businesses, Nabsys said.